We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · July 25, 2020

US Outpatient Prescription Trends for Hydroxychloroquine, Chloroquine, and Azithromycin

JAMA internal medicine

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA internal medicine
US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020
JAMA Intern Med 2020 Jul 06;[EPub Ahead of Print], N Shehab, M Lovegrove, DS Budnitz

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading